BG63204B1 - Нови таксоиди, получаването им и фармацевтични състави, които ги съдържат - Google Patents

Нови таксоиди, получаването им и фармацевтични състави, които ги съдържат Download PDF

Info

Publication number
BG63204B1
BG63204B1 BG102569A BG10256998A BG63204B1 BG 63204 B1 BG63204 B1 BG 63204B1 BG 102569 A BG102569 A BG 102569A BG 10256998 A BG10256998 A BG 10256998A BG 63204 B1 BG63204 B1 BG 63204B1
Authority
BG
Bulgaria
Prior art keywords
radical
carbon atoms
hydrogen atom
together form
radicals
Prior art date
Application number
BG102569A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102569A (en
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of BG102569A publication Critical patent/BG102569A/xx
Publication of BG63204B1 publication Critical patent/BG63204B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG102569A 1995-12-22 1998-06-22 Нови таксоиди, получаването им и фармацевтични състави, които ги съдържат BG63204B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1996/002031 WO1997023473A1 (fr) 1995-12-22 1996-12-19 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
BG102569A BG102569A (en) 1999-04-30
BG63204B1 true BG63204B1 (bg) 2001-06-29

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102569A BG63204B1 (bg) 1995-12-22 1998-06-22 Нови таксоиди, получаването им и фармацевтични състави, които ги съдържат

Country Status (41)

Country Link
US (1) US5728849A (zh)
EP (1) EP0876362B1 (zh)
JP (1) JP3953106B2 (zh)
KR (1) KR100500351B1 (zh)
CN (1) CN1103766C (zh)
AR (1) AR005197A1 (zh)
AT (1) ATE250593T1 (zh)
AU (1) AU712597B2 (zh)
BG (1) BG63204B1 (zh)
BR (1) BR9612135A (zh)
CA (1) CA2238884C (zh)
CO (1) CO4520184A1 (zh)
CZ (1) CZ294972B6 (zh)
DE (1) DE69630145T2 (zh)
DK (1) DK0876362T3 (zh)
DZ (1) DZ2149A1 (zh)
EA (1) EA001533B1 (zh)
ES (1) ES2202490T3 (zh)
FR (1) FR2742751B1 (zh)
HK (1) HK1017895A1 (zh)
HU (1) HU225032B1 (zh)
IL (1) IL124994A (zh)
IN (4) IN186768B (zh)
MA (1) MA26412A1 (zh)
MX (1) MX9804688A (zh)
MY (1) MY113934A (zh)
NO (1) NO317358B1 (zh)
NZ (1) NZ324337A (zh)
OA (1) OA10700A (zh)
PE (1) PE25198A1 (zh)
PL (1) PL189311B1 (zh)
PT (1) PT876362E (zh)
RO (1) RO116194B1 (zh)
SK (1) SK282835B6 (zh)
TN (1) TNSN96169A1 (zh)
TR (1) TR199801179T2 (zh)
TW (1) TW371659B (zh)
UA (1) UA48205C2 (zh)
UY (1) UY24386A1 (zh)
WO (1) WO1997023473A1 (zh)
ZA (1) ZA9610737B (zh)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
HUP0200759A3 (en) 2000-02-02 2002-10-28 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents and pharmaceutical compositions containing them and their use
HU230382B1 (hu) * 2001-02-24 2016-03-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantinszármazékok, előállításuk és alkalmazásuk gyógyszerként
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
NZ619413A (en) 2006-05-04 2015-08-28 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
CA2735562C (en) * 2008-08-15 2017-10-17 Boehringer Ingelheim International Gmbh Dpp-4 inhibitors for wound healing
RU2011113823A (ru) 2008-09-10 2012-10-20 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
JP2013512229A (ja) 2009-11-27 2013-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療
BR112012028136A2 (pt) 2010-05-05 2016-08-09 Boehringer Ingelheim Int terapia de combinaçao
EP3725325B1 (en) 2010-06-24 2023-05-31 Boehringer Ingelheim International GmbH Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
CN103781788B (zh) 2011-07-15 2016-08-17 勃林格殷格翰国际有限公司 经取代的喹唑啉、其制备及其在药物组合物中的用途
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
AU2012395148B2 (en) 2012-11-24 2016-10-27 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
MX2018015089A (es) 2016-06-10 2019-05-13 Boehringer Ingelheim Int Combinacion de linagliptina y metformina.
US20210308277A1 (en) 2016-11-14 2021-10-07 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
EP0639186B1 (en) * 1992-04-17 1999-06-23 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
HUP9904046A1 (hu) 2001-04-28
PE25198A1 (es) 1998-05-10
RO116194B1 (ro) 2000-11-30
BG102569A (en) 1999-04-30
CN1205697A (zh) 1999-01-20
CZ196198A3 (cs) 1998-09-16
DE69630145T2 (de) 2004-07-15
JP2000502671A (ja) 2000-03-07
EA199800588A1 (ru) 1998-12-24
NZ324337A (en) 2000-03-27
IN188470B (zh) 2002-09-28
FR2742751A1 (fr) 1997-06-27
HK1017895A1 (en) 1999-12-03
KR100500351B1 (ko) 2005-12-21
PL327405A1 (en) 1998-12-07
CO4520184A1 (es) 1997-10-15
HU225032B1 (en) 2006-05-29
EP0876362A1 (fr) 1998-11-11
ES2202490T3 (es) 2004-04-01
IN186768B (zh) 2001-11-03
HUP9904046A3 (en) 2001-08-28
PT876362E (pt) 2004-02-27
IN188680B (zh) 2002-10-26
ATE250593T1 (de) 2003-10-15
AU712597B2 (en) 1999-11-11
CA2238884A1 (fr) 1997-07-03
WO1997023473A1 (fr) 1997-07-03
BR9612135A (pt) 1999-07-13
AU1180997A (en) 1997-07-17
PL189311B1 (pl) 2005-07-29
IL124994A (en) 2000-12-06
NO982580D0 (no) 1998-06-05
FR2742751B1 (fr) 1998-01-30
CN1103766C (zh) 2003-03-26
TW371659B (en) 1999-10-11
TR199801179T2 (xx) 1998-10-21
OA10700A (fr) 2002-11-27
IL124994A0 (en) 1999-01-26
EP0876362B1 (fr) 2003-09-24
DE69630145D1 (de) 2003-10-30
CZ294972B6 (cs) 2005-04-13
KR19990076680A (ko) 1999-10-15
JP3953106B2 (ja) 2007-08-08
ZA9610737B (en) 1997-06-27
UA48205C2 (uk) 2002-08-15
UY24386A1 (es) 2001-08-27
SK85398A3 (en) 1998-11-04
DZ2149A1 (fr) 2002-10-23
DK0876362T3 (da) 2004-02-02
CA2238884C (fr) 2007-02-06
NO982580L (no) 1998-06-05
MY113934A (en) 2002-06-29
IN188469B (zh) 2002-09-28
EA001533B1 (ru) 2001-04-23
NO317358B1 (no) 2004-10-18
US5728849A (en) 1998-03-17
MX9804688A (es) 1998-10-31
SK282835B6 (sk) 2002-12-03
AR005197A1 (es) 1999-04-14
TNSN96169A1 (fr) 2005-03-15
MA26412A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
BG63204B1 (bg) Нови таксоиди, получаването им и фармацевтични състави, които ги съдържат
US5847170A (en) Taxoids, their preparation and pharmaceutical compositions containing them
AP753A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same.
US5571917A (en) Taxoid intermediates
US5906990A (en) Taxoids, preparation thereof, and pharmaceutical compositions containing same
US6194582B1 (en) Taxoids, their preparation and pharmaceutical compositions containing them
AP1023A (en) Taxoids, preparation thereof and pharmaceutical compositions containing same.
CA2214322C (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6372780B2 (en) Methods of treating cell lines expressing multidrug resistance P-glycoprotein
FR2707293A1 (fr) Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5840931A (en) Taxoids, their preparation and pharmaceutical compositions containing them
EP0874838A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2214320C (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732340A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent